(%)
Market is Open
Last quote from:
After-Hours Quote
Market is closed for
(%)
After-Hours Quote is Unavailable
Market is Open
Last quote from:
After-Hours Quote
Market is closed for
(%)
After-Hours Quote is Unavailable
- Ownership
-
Vallon Pharmaceuticals, Inc. Insider Trading
* In original currency USD
Loading Data
| Transaction Date (SEC Report) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price | Total Amount |
|---|---|---|---|---|---|---|---|---|
| Friday, September 22nd, 2023 | Kelly Leanne | officer: Chief Financial Officer | 83,333 | A-Award | A | 83,333 | 1.52 USD | 126,666 USD |
| Thursday, August 10th, 2023 | Szekeres David Leslie | director | 34,483 | A-Award | A | 34,483 | 2.90 USD | 100,001 USD |
| Thursday, August 10th, 2023 | SIMPSON CAMILLA V | director | 34,483 | A-Award | A | 34,483 | 2.90 USD | 100,001 USD |
| Thursday, August 10th, 2023 | Rongen Roelof | director | 34,483 | A-Award | A | 34,483 | 2.90 USD | 100,001 USD |
| Thursday, August 10th, 2023 | Baker David Charles | director | 34,483 | A-Award | A | 34,483 | 2.90 USD | 100,001 USD |
| Friday, April 21st, 2023 | Chaturvedi Vipin | officer | 0 | 0 | 0.00 USD | 0 USD | ||
| Friday, April 21st, 2023 | SIMPSON CAMILLA V | director: | 0 | 0 | 0.00 USD | 0 USD | ||
| Friday, April 21st, 2023 | Agro Albert | officer | 0 | 0 | 0.00 USD | 0 USD | ||
| Friday, April 21st, 2023 | Rongen Roelof | director: | 0 | 0 | 0.00 USD | 0 USD | ||
| Friday, April 21st, 2023 | Hertz Walter Marc | director, 10 percent owner, officer: Chief Executive Officer | 0 | 0 | 0.00 USD | 0 USD | ||
| Friday, April 21st, 2023 | Hertz Walter Marc | director, 10 percent owner, officer: Chief Executive Officer | 385,510 | A-Award | A | 385,510 | 0.00 USD | 0 USD |
| Friday, April 21st, 2023 | Agro Albert | officer: Chief Medical Officer | 172,189 | A-Award | A | 172,189 | 0.00 USD | 0 USD |
| Friday, April 21st, 2023 | Chaturvedi Vipin | officer: Chief Scientific Officer | 172,189 | A-Award | A | 172,189 | 0.00 USD | 0 USD |
| Friday, April 21st, 2023 | Szekeres David Leslie | director: | 0 | 0 | 0.00 USD | 0 USD | ||
| Tuesday, December 13th, 2022 | Thorell Marella | director | 9,506 | J-Other | D | 28,517 | 0.00 USD | 0 USD |
| Friday, July 1st, 2022 | Thorell Marella | director: | 38,023 | A-Award | A | 38,023 | 0.00 USD | 0 USD |
| Thursday, June 9th, 2022 | Ammer Richard | director: | 7,500 | A-Award | A | 7,500 | 0.00 USD | 0 USD |
| Thursday, June 9th, 2022 | Payne Joseph E | director: | 7,500 | A-Award | A | 7,500 | 0.00 USD | 0 USD |
| Thursday, June 9th, 2022 | Thorell Marella | director: | 7,500 | A-Award | A | 7,500 | 0.00 USD | 0 USD |
| Thursday, June 9th, 2022 | Thorell Marella | director | 7,500 | A-Award | A | 7,500 | 0.51 USD | 3,825 USD |
| Wednesday, February 23rd, 2022 | Chhabra Meenu | director | 15,000 | A-Award | A | 15,000 | 7.67 USD | 115,050 USD |
| Wednesday, February 23rd, 2022 | Chhabra Meenu | director: | 0 | 0 | 0.00 USD | 0 USD | ||
| Tuesday, February 15th, 2022 | Baker David Charles | director, officer: Chief Executive Officer | 61,000 | A-Award | A | 61,000 | 5.63 USD | 343,430 USD |
| Tuesday, February 15th, 2022 | Kelly Leanne M. | officer: Chief Financial Officer | 50,000 | A-Award | A | 50,000 | 5.63 USD | 281,500 USD |
| Friday, June 4th, 2021 | Kelly Leanne M. | officer: Chief Financial Officer | 6,250 | P-Purchase | A | 1,508 | 4.08 USD | 6,153 USD |
| Thursday, June 3rd, 2021 | Kelly Leanne M. | officer: Chief Financial Officer | 4,742 | P-Purchase | A | 1,085 | 4.05 USD | 4,394 USD |
| Wednesday, June 2nd, 2021 | Kelly Leanne M. | officer: Chief Financial Officer | 3,657 | P-Purchase | A | 3,657 | 4.00 USD | 14,628 USD |
| Wednesday, May 26th, 2021 | Payne Joseph E | director | 17,500 | P-Purchase | A | 6,800 | 4.50 USD | 30,600 USD |
| Tuesday, May 25th, 2021 | Payne Joseph E | director | 10,700 | P-Purchase | A | 10,700 | 3.85 USD | 41,195 USD |
| Friday, May 14th, 2021 | Payne Joseph E | director | 15,000 | A-Award | A | 15,000 | 3.66 USD | 54,900 USD |
| Friday, May 14th, 2021 | Payne Joseph E | director | 14,286 | A-Award | A | 14,286 | 3.66 USD | 52,287 USD |
| Friday, May 14th, 2021 | Ammer Richard | director | 15,000 | A-Award | A | 15,000 | 3.66 USD | 54,900 USD |
| Friday, May 14th, 2021 | Ammer Richard | director | 10,204 | A-Award | A | 10,204 | 3.66 USD | 37,347 USD |
| Friday, May 14th, 2021 | Levi Ofir | director | 30,000 | A-Award | A | 30,000 | 3.66 USD | 109,800 USD |
| Friday, May 14th, 2021 | Levi Ofir | director | 15,000 | A-Award | A | 15,000 | 3.66 USD | 54,900 USD |
| Friday, May 14th, 2021 | Kelly Leanne M. | officer: Chief Financial Officer | 70,000 | A-Award | A | 70,000 | 3.66 USD | 256,200 USD |
| Friday, May 14th, 2021 | Toren Penny | officer: SVP, Regul Affairs & Prog Mgmt | 25,000 | A-Award | A | 25,000 | 3.66 USD | 91,500 USD |
| Friday, May 14th, 2021 | Baker David Charles | director, officer: Chief Executive Officer | 100,000 | A-Award | A | 100,000 | 3.66 USD | 366,000 USD |
| Tuesday, May 11th, 2021 | Kelly Leanne M. | officer | 0 | 0 | 0.00 USD | 0 USD | ||
| Friday, February 12th, 2021 | Ammer Richard | director | 47,063 | J-Other | A | 47,063 | 6.40 USD | 301,203 USD |
| Friday, February 12th, 2021 | SALMON Pharma GmbH | 10 percent owner | 47,063 | J-Other | A | 47,063 | 6.40 USD | 301,203 USD |
| Friday, February 12th, 2021 | Thorell Marella | director | 15,000 | A-Award | A | 15,000 | 8.00 USD | 120,000 USD |
| Friday, February 12th, 2021 | Baker David Charles | director, officer: Chief Executive Officer | 8,843 | P-Purchase | A | 1,000 | 8.00 USD | 8,000 USD |
| Friday, February 12th, 2021 | Baker David Charles | director, officer: Chief Executive Officer | 7,843 | J-Other | A | 7,843 | 6.40 USD | 50,195 USD |
| Tuesday, February 9th, 2021 | Payne Joseph E | director, 10 percent owner: | 843,750 | I | 0 | 0.00 USD | 0 USD | |
| Tuesday, February 9th, 2021 | Arcturus Therapeutics Holdings Inc. | 10 percent owner | 843,750 | D | 0 | 0.00 USD | 0 USD | |
| Tuesday, February 9th, 2021 | Thorell Marella | director: | 0 | 0 | 0.00 USD | 0 USD | ||
| Tuesday, January 15th, 2019 | Baker David Charles | director, officer: Chief Executive Officer | 0 | D | 46,875 | 1.84 USD | 86,250 USD | |
| Thursday, February 4th, 2021 | Baker David Charles | director, officer: Chief Executive Officer | 0 | D | 61,250 | 2.20 USD | 134,750 USD | |
| Tuesday, February 9th, 2021 | Levi Ofir | director | 196,875 | D | 0 | 0.00 USD | 0 USD | |
| Tuesday, February 9th, 2021 | Ammer Richard | director, 10 percent owner: | 1,476,734 | I | 0 | 0.00 USD | 0 USD | |
| Tuesday, February 9th, 2021 | SALMON Pharma GmbH | 10 percent owner | 1,476,734 | D | 0 | 0.00 USD | 0 USD | |
| Monday, October 1st, 2018 | Toren Penny | officer: SVP, Regul Affairs & Prog Mgmt | 0 | D | 7,813 | 1.84 USD | 14,376 USD | |
| Tuesday, February 9th, 2021 | Toren Penny | officer: SVP, Regul Affairs & Prog Mgmt | 0 | D | 5,000 | 3.82 USD | 19,100 USD |
